As Super-EBS inhibits the growth of lung and prostate cancer cells that have undergone NED, we tested p-S6K1 levels in A549 or LNCaP cells that were induced to undergo NED following treatment with Super-EBS. The gene discussed is RPS6KB1; the disease is prostate carcinoma.